Clinical trial
Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for…
NCT00070057 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00070057 |
|---|---|
| Title | Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer |
| Official title | An Exploratory, Open-Label Phase I Pharmacodynamic Study of COX-2 Inhibition With Celecoxib (Celebrex) and Aromatase Activity in Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | celecoxib, therapeutic conventional surgery, pharmacological study, laboratory biomarker analysis |
| Enrollment | 75 |
| Start date | Apr 1, 2003 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Oct 7, 2003 |
| Last update posted | Dec 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: